Side effects from hctz
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Hydrochlorothiazide (HCTZ)
Hydrochlorothiazide (HCTZ) is a widely prescribed diuretic used primarily for managing hypertension and heart failure. Despite its effectiveness, HCTZ is associated with a range of side effects, some common and others rare but severe. This article synthesizes the findings from multiple studies to provide a comprehensive overview of the side effects linked to HCTZ.
Common Side Effects: Electrolyte Imbalances and Metabolic Changes
Hypokalemia and Hyperglycemia
One of the most frequently reported side effects of HCTZ is hypokalemia, a condition characterized by low potassium levels in the blood. This can lead to symptoms such as muscle weakness, cramps, and fatigue2 9. Additionally, HCTZ has been associated with hyperglycemia, which can exacerbate or lead to the development of diabetes2 7.
Hyperuricemia and Gout
HCTZ can increase serum urate concentrations, leading to hyperuricemia and potentially causing gout. A genome-wide association study identified specific genetic markers that may predispose individuals to this side effect3. This highlights the importance of monitoring urate levels in patients on HCTZ therapy.
Hypertriglyceridemia and Insulin Resistance
HCTZ has also been linked to metabolic abnormalities such as hypertriglyceridemia and insulin resistance. These changes can increase the risk of cardiovascular diseases and complicate the management of existing conditions2 7.
Severe and Rare Side Effects
Allergic Reactions and Hypersensitivity
Although rare, severe allergic reactions to HCTZ can occur. These reactions can mimic conditions like septic shock, making diagnosis challenging. Symptoms may include dyspnea, severe fatigue, and other signs of systemic hypersensitivity1. Clinicians should be vigilant for these reactions, especially in patients with a history of allergies to sulfonamide drugs.
Renal and Endothelial Dysfunction
HCTZ can cause subtle renal injury and impair endothelial function, particularly in the presence of hypokalemia. Studies in animal models have shown that HCTZ treatment can lead to increased kidney weight, glomerular ischemia, and medullary injury, along with reduced endothelium-dependent vasorelaxation2.
Pulmonary Edema
A particularly dangerous but rare side effect of HCTZ is acute pulmonary edema. This condition can present with symptoms such as acute respiratory failure, fever, vomiting, and diarrhea shortly after taking the medication5. This underscores the need for immediate medical attention if such symptoms occur.
Increased Risk of Skin Cancer
Photosensitivity and Carcinogenic Potential
HCTZ increases skin sensitivity to sunlight, which can lead to photosensitivity reactions. More concerning, however, is the increased risk of non-melanoma skin cancer. Studies have shown a significant association between HCTZ use and the development of basal cell carcinoma and squamous cell carcinoma6. This has led to HCTZ being classified as a carcinogenic agent by health authorities.
Conclusion
While HCTZ is effective in managing hypertension and heart failure, its use is accompanied by a range of side effects, from common electrolyte imbalances and metabolic changes to rare but severe allergic reactions and increased cancer risk. Clinicians should carefully monitor patients on HCTZ for these side effects and consider alternative treatments for those at higher risk.
Sources and full results
Most relevant research papers on this topic